Cargando…

The Association of Ascorbic Acid, Deferoxamine and N-Acetylcysteine Improves Cardiac Fibroblast Viability and Cellular Function Associated with Tissue Repair Damaged by Simulated Ischemia/Reperfusion

Acute myocardial infarction is one of the leading causes of death worldwide and thus, an extensively studied disease. Nonetheless, the effects of ischemia/reperfusion injury elicited by oxidative stress on cardiac fibroblast function associated with tissue repair are not completely understood. Ascor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parra-Flores, Pablo, Riquelme, Jaime A, Valenzuela-Bustamante, Paula, Leiva-Navarrete, Sebastian, Vivar, Raúl, Cayupi-Vivanco, Jossete, Castro, Esteban, Espinoza-Pérez, Claudio, Ruz-Cortés, Felipe, Pedrozo, Zully, Lavandero, Sergio, Rodrigo, Ramon, Diaz-Araya, Guillermo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943610/ https://www.ncbi.nlm.nih.gov/pubmed/31817022 http://dx.doi.org/10.3390/antiox8120614

Ejemplares similares

Communication Between Cardiomyocytes and Fibroblasts During Cardiac Ischemia/Reperfusion and Remodeling: Roles of TGF-β, CTGF, the Renin Angiotensin Axis, and Non-coding RNA Molecules
por: Flores-Vergara, Raúl, et al.
Publicado: (2021)

Endothelial activation impairs the function of small extracellular vesicles
por: Herrera-Zelada, Nicolas, et al.
Publicado: (2023)

The Effects of Ascorbate, N-Acetylcysteine, and Resveratrol on Fibroblasts from Patients with Mitochondrial Disorders
por: Douiev, Liza, et al.
Publicado: (2016)

Activation of Chymotrypsin-Like Activity of the Proteasome during Ischemia Induces Myocardial Dysfunction and Death
por: Sanchez, Gina, et al.
Publicado: (2016)

Inhibition of chymotrypsin-like activity of the proteasome by ixazomib prevents mitochondrial dysfunction during myocardial ischemia
por: Sánchez, Gina, et al.
Publicado: (2020)

N-acetylcysteine, Ascorbic Acid, and Methylene Blue for the Treatment of Aluminium Phosphide Poisoning: Still Beneficial?
por: Gheshlaghi, Farzad, et al.
Publicado: (2015)

Comparison of N-acetylcysteine, ascorbic acid, and normal saline effect in prevention of contrast-induced nephropathy
por: Khaledifar, Arsalan, et al.
Publicado: (2015)

N-acetylcysteine plus deferoxamine for patients with prolonged hypotension does not decrease acute kidney injury incidence: a double blind, randomized, placebo-controlled trial
por: Fraga, Cassiana Mazon, et al.
Publicado: (2016)

Curcumin and N-Acetylcysteine Nanocarriers Alone or Combined with Deferoxamine Target the Mitochondria and Protect against Neurotoxicity and Oxidative Stress in a Co-Culture Model of Parkinson’s Disease
por: Mursaleen, Leah, et al.
Publicado: (2023)

Comparison of the effects of deferasirox, deferoxamine, and combination of deferasirox and deferoxamine on an aplastic anemia mouse model complicated with iron overload
por: Wu, Dijiong, et al.
Publicado: (2018)

Herpud1 negatively regulates pathological cardiac hypertrophy by inducing IP3 receptor degradation
por: Torrealba, Natalia, et al.
Publicado: (2017)

New Molecular and Organelle Alterations Linked to Down Syndrome Heart Disease
por: Venegas-Zamora, Leslye, et al.
Publicado: (2022)

Efficacy of N-Acetylcysteine, Glutathione, and Ascorbic Acid in Acute Toxicity of Paraoxon to Wistar Rats: Survival Study
por: Nurulain, Syed M., et al.
Publicado: (2015)

Comparison of iron chelation effects of deferoxamine, deferasirox, and combination of deferoxamine and deferiprone on liver and cardiac T2* MRI in thalassemia maior
por: Ansari, Shahla, et al.
Publicado: (2017)

Polycystin-1 Is a Crucial Regulator of BIN1 Expression and T-Tubule Remodeling Associated with the Development of Dilated Cardiomyopathy
por: Díaz-Vesga, Magda C., et al.
Publicado: (2022)

Model-Based Optimisation of Deferoxamine Chelation Therapy
por: Bellanti, Francesco, et al.
Publicado: (2015)

Abstract: Deferoxamine Increases Breast Cancer Radiosensitivity
por: Ranganathan, Kavitha, et al.
Publicado: (2018)

Mechanisms of Intranasal Deferoxamine in Neurodegenerative and Neurovascular Disease
por: Kosyakovsky, Jacob, et al.
Publicado: (2021)

Deferoxamine Reduces Inflammation and Osteoclastogenesis in Avulsed Teeth
por: Lee, Ko Eun, et al.
Publicado: (2021)

Iron Neurotoxicity and Protection by Deferoxamine in Intracerebral Hemorrhage
por: Li, Zhe, et al.
Publicado: (2022)

Effects of N-acetylcysteine on Growth, Viability, and Ultrastructure of In Vitro Cultured Bovine Secondary Follicles
por: Nascimento, Danisvânia R., et al.
Publicado: (2022)

Polycystin-1 is required for insulin-like growth factor 1-induced cardiomyocyte hypertrophy
por: Fernández, Carolina, et al.
Publicado: (2021)

Deferoxamine inhibition of malaria is independent of host iron status
Publicado: (1988)

Comparison of the effect of vanadium and deferoxamine on acetaminophen toxicity in rats
por: Najafzadeh, H., et al.
Publicado: (2011)

Iron Accumulates in Huntington’s Disease Neurons: Protection by Deferoxamine
por: Chen, Jianfang, et al.
Publicado: (2013)

Deferoxamine therapy for intracerebral hemorrhage: A systematic review
por: Zeng, Liling, et al.
Publicado: (2018)

Effects of Deferoxamine on Leukemia In Vitro and Its Related Mechanism
por: Yang, Yujing, et al.
Publicado: (2018)

The effect of deferoxamine injection on composite graft survival in rabbits
por: Ramli, Rianto Noviady, et al.
Publicado: (2020)

The iron chelator deferoxamine decreases myeloma cell survival
por: Yang, Feifei, et al.
Publicado: (2021)

Effects of deferoxamine on intrinsic colistin resistance of Proteus mirabilis
por: Erinmez, Mehmet, et al.
Publicado: (2023)

Cardiac and hepatic iron and ejection fraction in thalassemia major: Multicentre prospective comparison of combined Deferiprone and Deferoxamine therapy against Deferiprone or Deferoxamine Monotherapy
por: Pepe, Alessia, et al.
Publicado: (2013)

Synergistic Protection of N-Acetylcysteine and Ascorbic Acid 2-Phosphate on Human Mesenchymal Stem cells Against Mitoptosis, Necroptosis and Apoptosis
por: Li, Chia-Jung, et al.
Publicado: (2015)

The impact of N-acetylcysteine and ascorbic acid in contrast-induced nephropathy in critical care patients: an open-label randomized controlled study
por: Palli, Eleni, et al.
Publicado: (2017)

N-acetylcystein in dengue associated severe hepatitis
por: Habaragamuwa, Buddhika Widyaratna Peiris, et al.
Publicado: (2014)

Correction: Iron Accumulates in Huntington’s Disease Neurons: Protection by Deferoxamine
por: Chen, Jianfang, et al.
Publicado: (2013)

The Clinical Effect of Deferoxamine Mesylate on Edema after Intracerebral Hemorrhage
por: Yu, Yao, et al.
Publicado: (2015)

Deferoxamine attenuates lipopolysaccharide-induced neuroinflammation and memory impairment in mice
por: Zhang, Xiao-Ying, et al.
Publicado: (2015)

Chelation of gadolinium with deferoxamine in a patient with nephrogenic systemic fibrosis
por: Leung, Nelson, et al.
Publicado: (2009)

Functional and Structural Abnormalities in Deferoxamine Retinopathy: A Review of the Literature
por: Di Nicola, Maura, et al.
Publicado: (2015)

Deferoxamine retinopathy: spectral domain-optical coherence tomography findings
por: Wu, Cheng-Hsiu, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_cit0hfeq1acc8lr2c664idebqg